Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 37,647 | 55,198 | 47,830 | 43,660 | 38,620 |
| Cost of Goods | 18,681 | 16,589 | 14,907 | 13,221 | 13,192 |
| Gross Profit | 18,966 | 38,609 | 32,923 | 30,439 | 25,428 |
| Operating Expenses | 76,840 | 78,384 | 79,261 | 83,162 | 88,687 |
| Operating Income | -57,193 | -39,186 | -45,431 | -52,502 | -63,067 |
| Interest Expense | 3,531 | 3,585 | 653 | 0 | 0 |
| Other Income | 3,024 | 2,602 | 765 | 418 | 271 |
| Pre-tax Income | -57,700 | -40,169 | -45,319 | -52,084 | -62,796 |
| Net Income Continuous | -57,700 | -40,169 | -45,319 | -52,084 | -62,796 |
| Minority Interests | -1 | -41 | -38 | -38 | -60 |
| Net Income | $-57,699 | $-40,128 | $-45,281 | $-52,046 | $-62,736 |
| EPS Basic Total Ops | -0.40 | -0.27 | -0.32 | -0.37 | -0.44 |
| EPS Basic Continuous Ops | -0.40 | -0.28 | -0.32 | -0.37 | -0.44 |
| EPS Diluted Total Ops | -0.40 | -0.27 | -0.32 | -0.37 | -0.44 |
| EPS Diluted Continuous Ops | -0.40 | -0.28 | -0.32 | -0.37 | -0.44 |
| EBITDA(a) | $-53,379 | $-34,984 | $-39,637 | $-46,755 | $-57,149 |